Skip to main content
. 2020 Sep 14;13(9):245. doi: 10.3390/ph13090245

Figure 6.

Figure 6

Homogeneous ADC with a DAR 4 comprising a biparatopic anti-HER2 antibody conjugated to a tubulysin derivative via a classical maleimidocaproic linker.